近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Online coupling of hydrophilic interaction/strong cation exchange/reversed-phase liquid chromatography with porous graphitic carbon liquid chromatography for simultaneous proteomics and N-glycomics analysis. J Chromatogr A. 2015 Aug 19.
2. Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson’s disease. Free radical biology and medicine. 2015. Jul;84:331-43
3. A potent multifunctional neuroprotective derivative of tetramethylpyrazine. Journal of Molecular Neuroscience. 2015. Aug;56(4):977-87.
4. Discovery of novel anti-Parkinsonian effect of Schisantherin A in in vitro and in vivo. Neuroscience Letters 2015. Mar 11;593:7-12.
5. Pharmacokinetic study and optimal formulation of new anti-Parkinson natural compound Schisantherin A. Parkinson’s Disease 2015. Article ID 951361.
6. Protective effect of edaravone in primary cerebellar granule neurons against iodoacetic acid-induced cell injury. Oxidative medicine and cellular longevity. 2014. In press.
7. A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-kappa B and the PKCalpha/PI3-K/Akt pathways. Neurochemistry International. 2014.78: 76-85.
8. Neuroprotective effects of the Andrographolide analogue AL-1 in the MPP+/MPTP-induced Parkinson’s disease model in vitro and in mice. Pharmacology Biochemistry and Behavior. 2014. Apr 12;122C:191-202.
9. The novel tetramethylpyrazine bis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis. 2014. J Neuroimmune Pharmacol. Mar;9(2):245-58.
10. Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction. CNS Neurosci Ther. 2014. Mar;20(3):244-52.
京公网安备 11010802027423号